Market Highlights: MaxCyte Inc (MXCT) Ends on a High Note at 3.63

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of MaxCyte Inc (NASDAQ: MXCT) closed at $3.63 in the last session, up 2.25% from day before closing price of $3.55. In other words, the price has increased by $2.25 from its previous closing price. On the day, 0.66 million shares were traded. MXCT stock price reached its highest trading level at $3.695 during the session, while it also had its lowest trading level at $3.53.

Ratios:

We take a closer look at MXCT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.22 and its Current Ratio is at 9.81. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on November 29, 2023, initiated with a Buy rating and assigned the stock a target price of $7.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 01 ’24 when Erck Stanley C sold 47,689 shares for $3.72 per share. The transaction valued at 177,403 led to the insider holds 269,118 shares of the business.

Johnston John Joseph sold 3,000 shares of MXCT for $11,166 on Oct 28 ’24. The Director now owns 141,950 shares after completing the transaction at $3.72 per share. On Oct 01 ’24, another insider, Erck Stanley C, who serves as the Director of the company, sold 26,082 shares for $3.78 each. As a result, the insider received 98,590 and left with 269,118 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MXCT now has a Market Capitalization of 382903296 and an Enterprise Value of 247388688. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.47 while its Price-to-Book (P/B) ratio in mrq is 1.79. Its current Enterprise Value per Revenue stands at 5.425 whereas that against EBITDA is -5.886.

Stock Price History:

Over the past 52 weeks, MXCT has reached a high of $5.55, while it has fallen to a 52-week low of $3.16. The 50-Day Moving Average of the stock is -1.09%, while the 200-Day Moving Average is calculated to be -12.26%.

Shares Statistics:

According to the various share statistics, MXCT traded on average about 470.36K shares per day over the past 3-months and 877920 shares per day over the past 10 days. A total of 105.30M shares are outstanding, with a floating share count of 97.34M. Insiders hold about 7.72% of the company’s shares, while institutions hold 65.11% stake in the company. Shares short for MXCT as of 1731628800 were 3322793 with a Short Ratio of 7.06, compared to 1728950400 on 3508938. Therefore, it implies a Short% of Shares Outstanding of 3322793 and a Short% of Float of 3.18.

Most Popular